- Home
- GAIA vs CRVO Comparison
GAIA vs CRVO Comparison
Compare GAIA & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GAIA
- CRVO
- Stock Information
- Founded
- GAIA 1988
- CRVO 2001
- Country
- GAIA United States
- CRVO United States
- Employees
- GAIA N/A
- CRVO N/A
- Industry
- GAIA Movies/Entertainment
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- GAIA Consumer Discretionary
- CRVO Health Care
- Exchange
- GAIA Nasdaq
- CRVO Nasdaq
- Market Cap
- GAIA 104.1M
- CRVO 95.4M
- IPO Year
- GAIA 1999
- CRVO N/A
- Fundamental
- Price
- GAIA $3.92
- CRVO $9.98
- Analyst Decision
- GAIA Strong Buy
- CRVO Strong Buy
- Analyst Count
- GAIA 2
- CRVO 8
- Target Price
- GAIA $8.00
- CRVO $25.43
- AVG Volume (30 Days)
- GAIA 31.2K
- CRVO 13.7M
- Earning Date
- GAIA 05-05-2025
- CRVO 03-17-2025
- Dividend Yield
- GAIA N/A
- CRVO N/A
- EPS Growth
- GAIA N/A
- CRVO N/A
- EPS
- GAIA N/A
- CRVO N/A
- Revenue
- GAIA $90,363,000.00
- CRVO $9,737,974.00
- Revenue This Year
- GAIA $14.66
- CRVO N/A
- Revenue Next Year
- GAIA $16.14
- CRVO N/A
- P/E Ratio
- GAIA N/A
- CRVO N/A
- Revenue Growth
- GAIA 12.36
- CRVO 36.29
- 52 Week Low
- GAIA $3.18
- CRVO $1.80
- 52 Week High
- GAIA $6.53
- CRVO $25.92
- Technical
- Relative Strength Index (RSI)
- GAIA 39.53
- CRVO 62.10
- Support Level
- GAIA $3.68
- CRVO $7.13
- Resistance Level
- GAIA $4.05
- CRVO $10.72
- Average True Range (ATR)
- GAIA 0.18
- CRVO 2.39
- MACD
- GAIA 0.01
- CRVO -0.03
- Stochastic Oscillator
- GAIA 36.36
- CRVO 39.69
About GAIA Gaia Inc.
Gaia Inc is a video streaming service and community that provides curated conscious media in primary channels; Seeking Truth provides new and enlightening perspectives for today's changing world; Transformation provides a wealth of content in the niche areas of spiritual growth, personal development, and expanded consciousness; Alternative Healing channel features content focused on food and nutrition, holistic healing, alternative and integrative medicines, and longevity, and Yoga. Geographically, it derives a majority of its revenue from the United States and also has an International presence.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.